MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Wednesday, June 22, 2016

12:00pm-1:30pm
Comparison of the utility of three cognitive scales for MDS Level-I diagnosis of mild cognitive impairment in Parkinson’s disease: MoCA, PD-CRS and ACE-III

R. Fernandez-Bobadilla, J. Pagonabarraga, J.A. Matias-Guiu, S. Martínez-Horta, A. Horta-Barba, J. Marin-Lahoz, J. Perez-Perez, B. Pascual-Sedano, H. Bejr-Kasem, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Compensation strategies for gait in Parkinson’s disease

S.C. Lidstone, A. Fasano, M. Hallett, A. Nieuwboer, E. Ruzicka, B.A. Bloem (Toronto, ON, Canada)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Computer uses and difficulties in Parkinson’s disease

Z. Katsarou, M. Plotnik, G. Zeilig, A. Gottlieb, R. Kizony, S. Bostantjopoulou (Thessaloniki, Greece)

Rating scales  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Consolidation of learning and memory in Parkinson’s disease

M.E. Sharp, K. Duncan, K. Foerde, R. Kahane, D. Shohamy (New York City, NY, USA)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Construct validity of Moca test in a sample of patients with Parkinson´s disease in Bogotá and Cali – Colombia

B.E. Muñoz, O. Bernal, A. Castillo, J.L. Orozco (Cali, Colombia)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Coping styles and their influence on outcomes in Parkinson’s disease

K.M. Sundvick, F. Kassam, N. Dispirito, E. Book, S. Cresswell (Vancovuer, BC, Canada)

Parkinson's disease: Psychiatric manifestations  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Core set of measures of balance for people with multiple sclerosis and cerebellar ataxia

S.J. Winser, C.M. Smith, L.A. Hale, L.S. Claydon, S.L. Whitney, B. Klatt, J. Mottershead, I. Zaydan, R. Heyman, S. Winser (Dunedin, New Zealand)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Corpus callosum thickness and area in Parkinson’s disease

I.O. Bledsoe, D. Merkitch, G. Stebbins, B. Bernard, J.G. Goldman (Chicago, IL, USA)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Correlation analysis for postural instability and autonomic dysfunction in patients with Parkinson’s disease

S. You, S.H. Lim, H. Lee, H.A. Kim (Dague, Korea)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Correlation between neuro-behavioral symptoms, cognition and gait in patients with dementia with Lewy bodies (DLB)

B. Tousi, L. Mourany (Cleveland, OH, USA)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 54
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley